NCT03097835 - Evaluation of Skin Quality Improvement | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 12, 2018

Primary Completion Date

July 12, 2018

Study Completion Date

July 26, 2018

Conditions

Skin Quality

Interventions

DRUG

Hyper-Diluted Botox

"0.1ml of hyper-diluted Botox® Cosmetic will be administered in the superficial dermis using a 1ml luer lock syringe coupled with a 33g ½ needle"

DRUG

Topical anesthesia

Topical anesthesia will be bilaterally applied to the mid-face region for 20 minutes

OTHER

0.9% saline solution

0.1ml of 0.9% saline solution will be administered to the side of the face

Trial Locations (1)

Steve Yoelin MD & Associates, Newport Beach